Percentage of GC B cells and PCs within donor-derived antigen-specific B cells in contralaterally HEL-OVA-boosted ndLN treated with isotype control or anti-CSF1R mAb. Data were pooled from two independent experiments. Each circle represents one mouse. Line and bar represent median.
